Research Article
Development of a Novel Vaccine Candidates against Cardiobacterium valvarum through Reverse Vaccinology and Computational Approaches
Table 2
T-cells epitopes and percentile score.
| MHC-I | Percentile score | MHC-II | Percentile score |
| RSIEGQVDRF | 0.09 | DNRRSIEGQVDRF | 17 | DNRRSIEGQV | 12 | DNRRSIEGQVDRF | 17 | RPTADNRRSI | 0.04 | RPTADNRRSIEGQV | 44 | NRRSIEGQV | 9.8 | RPTADNRRSIEGQV | 44 | RSIEGQVDRF | 0.09 | RSIEGQVDRFGKVR | 26 | QVDRFGKVR | 1.4 | RSIEGQVDRFGKVR | 26 | TYLGASWNR | 0.03 | STYLGASWNRSTYH | 6.1 | ASWNRSTYH | 0.63 | STYLGASWNRSTYH | 6.1 | DVKGRDLRL | 0.08 | DVKGRDLRLPRSTYL | 9.2 | DLRLPRSTYL | 0.12 | DVKGRDLRLPRSTYL | 9.2 | KLNSALEYK | 0.02 | NWKLNSALEYK | 0.29 | NWKLNSALEY | 1.2 | NWKLNSALEYK | 0.29 | HQFNDNWKL | 0.06 | DHQFNDNWKLNSAL | 9.8 | DNWKLNSAL | 1.5 | DHQFNDNWKLNSAL | 9.8 | NVSASGTVS | 10 | YVPQRSNVSASGTVS | 5.2 | DWNALPEEV | 1.7 | QPADWNALPEEV | 1.4 | QPADWNALP | 4.1 | QPADWNALPEEV | 1.4 | IFRWQGTEI | 1.4 | YNIFRWQGTEIAQP | 4.2 | WQGTEIAQP | 11 | YNIFRWQGTEIAQP | 4.2 | WHGKKIAGE | 31 | WHGKKIAGE | 21 | KFDNTWHGK | 1.1 | REKFDNTWHGKKIA | 27 | NTWHGKKIA | 2.5 | REKFDNTWHGKKIA | 27 | HQHLSWMSK | 0.05 | HQHLSWMSKPDSK | 11 | LSWMSKPDSK | 0.85 | SWMSKPDSKYGKGRL | 48 | WMSKPDSKY | 0.08 | DSKYGKGRL | 2.6 | SWMSKPDSKYGKGRL | 48 | HQHLSWMSK | 0.05 | WQQHQHLSWMSKPDS | 20 | WQQHQHLSW | 0.59 | WQQHQHLSWMSKPDS | 20 | LSWMSKPDS | 21 | FKYSGDYLDINGKTL | 11 | YLDINGKTL | 0.14 | FKYSGDYLDI | 3.1 | FKYSGDYLDINGKTL | 11 |
|
|